Our Specialty portfolio delivers innovative medicines focused on meeting important medical needs across therapeutic categories, including central nervous system disorders (Parkinson’s Disease, Spasticity, Migraine), endocrinology (Hypothyroidism), and other therapeutic areas.
We are focused on the continued growth and expansion of our product portfolio through internal development as well as through acquisitions and late-stage and next-generation product partnership opportunities.
Migraine and Cluster Headache
Neurogenic Orthostatic Hypotension
*Pending completion of a requested QT safety study to resolve CRL and FDA approval
**As of November 2023